烟碱型胆碱受体α9(CHRNa9)重组蛋白说明书
Recombinant Cholinergic Receptor, Nicotinic, Alpha 9 (CHRNa9)
[PROPERTIES]
Source: Prokaryotic expression
Host: E.coli
Residues: Ala26~Ser237
Tags: N-terminal His and GST Tag
Subcellular Location: Membrane, Extracellular matrix
Purity: > 90%
Traits: Freeze-dried powder
Buffer formulation: 20mM Tris, 150mM NaCl, pH8.0, containing 0.01% skl, 5%Trehalose.
Original Concentration: 50µg/mL
Applications: Positive Control; Immunogen; SDS-PAGE; WB.
(May be suitable for use in other assays to be determined by the end user.)
Predicted isoelectric point: 4.2
Predicted Molecular Mass: 54.5kDa
Accurate Molecular Mass: 55kDa as determined by SDS-PAGE reducing conditions.
[USAGE]
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
[STORAGE AND STABILITY]
Storage: Avoid repeated freeze/thaw cycles.
Store at 2-8ºC for one month.
Aliquot and store at -80ºC for 12 months.
Stability Test: The thermal stability is described by the loss rate. The loss rate was determinedby accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and noobvious degradation and precipitation were observed. The loss rate is less than 5% within theexpiration date under appropriate storage condition.
[SEQUENCE]
[IDENTIFICATION]
[IMPORTANT NOTE]
The kit is designed for research use only, we will not be responsible for any issue if the kit wasused in clinical diagnostic or any other procedures.
本产品仅供科研使用。不能用于人和动物治疗等其它临床诊断使用